We have assembled a seasoned management team. Our leaders have played critical roles in the discovery and advancement of multiple first-in-class oncology therapeutics, from early-stage research through clinical trials, and ultimately to regulatory approval and commercialization, including Kisqali®, Onivyde®, Tafinlar®, Tazverik®, Velcade® and Zolinza®.

Join our team of experts.
Find Out More